Clinical Trial Update: The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the long-term effects of inhaled hypertonic saline 6% in patients with bronchiectasis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Inhaled Hypertonic Saline 6% (Hypertonic saline)

Snippet

Sponsor: The Alfred | Conditions: Bronchiectasis | Phase 3 | Status: COMPLETED